Fundraising Fox

Encellin

San Francisco, US · Founded 2015 · Delaware corporation · 8 known investors

encellin.com

Encellin develops next-generation therapies for patients with chronic unmet clinical needs, using technology originating from Dr. Tejal Desai's laboratory at UCSF that combines micro and nanotechnologies with novel drug delivery approaches. The company focuses on therapeutic delivery platforms and cell-based treatments, particularly for diseases including diabetes and autoimmune conditions.

BiotechDeep TechHealthtechMedical Devicesin /encellin@encellin_inc

Founders & leadership

TD
Tejal DesaiTechnology Expert, Founder
RM
Ronald MartellStrategic Advisor, Founder
CNCrystal Nyitray
Crystal NyitrayExecutive Officer, Director, Promoter
GWGrace Wei
Grace WeiExecutive Officer, Director, Promoter
MD
Maria del Consuelo ValverdeDirector

Investors · 8

Reported raises · per SEC filings

Form D private placements
$9.9MraisedDec 2023 · 26 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Crystal NyitrayExecutive Officer, Director
  • Maria del Consuelo ValverdeDirector
  • Grace WeiDirector
Offering amount
$9.9M
Amount sold
$9.9M
First sale
Sep 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$2.1MraisedJul 2019 · 7 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Crystal NyitrayExecutive Officer, Director, Promoter
  • Grace WeiExecutive Officer, Director, Promoter
  • Ronald MartellExecutive Officer, Director
  • Maria del Consuelo ValverdeDirector
Offering amount
$2.7M
Amount sold
$2.1M
First sale
Jun 2019
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news